Bausch Health
BHC
#3916
Rank
NZ$5.89 B
Marketcap
NZ$15.77
Share price
28.76%
Change (1 day)
54.07%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): NZ-$5.11

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.22. In 2025 the company made an earnings per share (EPS) of NZ$0.74 an increase over its 2024 EPS that were of NZ-$0.21.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.11-787.49%
2025NZ$0.74-450%
2024NZ-$0.21-92.59%
2023NZ-$2.87160.89%
2022NZ-$1.10-76.64%
2021NZ-$4.7068.45%
2020NZ-$2.79-68.91%
2019NZ-$8.98-57.11%
2018NZ-$20.94-272.22%
2017NZ$12.16-199.29%
2016NZ-$12.25798.7%
2015NZ-$1.36-128.31%
2014NZ$4.81-204.62%
2013NZ-$4.60602.7%
2012NZ-$0.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.16-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.68-67.80%๐Ÿ‡บ๐Ÿ‡ธ USA